Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 379

DECLARATION re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1), #378 Memorandum in Support of Motion, OF MARIO MOORE by Amgen Inc.. (Attachments: #1 Confidential Exhibit Coversheet#2 Exhibit 1#3 Exhibit 2#4 Exhibit 3# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7# 8 Exhibit 8# 9 Exhibit 9, Part 1 of 2# 10 Exhibit 9, Part 2 of 2# 11 Exhibit 10# 12 Exhibit 11# 13 Exhibit 12# 14 Exhibit 15# 15 Exhibit 16# 16 Exhibit 17# 17 Exhibit 18#18 Exhibit 19#19 Exhibit 20#20 Exhibit 21#21 Exhibit 22#22 Exhibit 25#23 Exhibit 26#24 Exhibit 27# 25 Exhibit 28# 26 Exhibit 29#27 Exhibit 30)(Gottfried, Michael) Additional attachment(s) added on 4/16/2007 (Paine, Matthew). Additional attachment(s) added on 4/16/2007 (Paine, Matthew).

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 379 Att. 20 Case 1:05-cv-12237-WGY Document 379-21 Filed 04/13/2007 Page 1 of 2 EXHIBIT 21 Dockets.Justia.com Case 1:05-cv-12237-WGY Document 379-21 Filed 04/13/2007 Page 2 of 2 From: Sent: To: Cc: Subject: Mark Hebert [Hebert@fr.com] Thursday, March 29, 2007 11:53 AM Fishman, Deborah; dcousineau@kayescholer.com; Carter, Krista; jbrew@kayescholer.com Mark Hebert; Michael Kallus; Joseph Patriss Fresenius production Attachments: FMCNA 003014 - 003027.pdf; FMCNA 003028-003034.pdf; FMCNA 003035-003040.pdf I am attaching the last 3 documents that we are producing in response to Amgen's subpoena. These are the documents that have been the subject of extensive e-mail traffic yesterday, which Roche has authorized to be produced. Please note that Roche requested a redaction on page 3027. I have asked Mr. Cousineau how we should designate these documents, but I have received no response. Perhaps he is traveling to Boston? In any event, out of an abundance of caution, I have designated these as "Highly Confidential." I'll leave it to counsel for Amgen and Roche to determine whether that designation is appropriate. - Mark Mark J. Hebert ~ Fish & Richardson P.C. 225 Franklin Street Boston, Massachusetts 02110-2804 Phone: (617) 542-5070 Fax: (617) 542-8906 NOTE: This email is for the use of the intended recipient only and may contain privileged or confidential information. If you have received this email in error, please notify the sender immediately. Thank you. ********************************************************************************************** This email message is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized use or disclosure is prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. IRS CIRCULAR 230 DISCLOSURE: Any U.S. tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. **********************************************************************************************

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?